CPB Versus Sham Treatment for Pain Management in Small Duct Chronic Pancreatitis
NCT ID: NCT02054910
Last Updated: 2017-02-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2013-10-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
NCT06178315
Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas
NCT01182831
Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis
NCT04037449
Application of Celiac Plexus Block in Postoperative Analgesia of Whipple Surgery
NCT05205720
The Application of Thoracic Epidural Analgesia in Patients With Acute Pancreatitis
NCT06327230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Celiac Plexus Block
Celiac Plexus Block will be administered following EUS
Celiac Plexus Block
Patients will receive celiac plexus block during endoscopy.
Sham
A celiac plexus block will not be administered for pain management
Sham
Patients will not receive celiac plexus block during endoscopy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Celiac Plexus Block
Patients will receive celiac plexus block during endoscopy.
Sham
Patients will not receive celiac plexus block during endoscopy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients referred to the endoscopy unit with abdominal pain with suspicion of chronic pancreatitis meeting 5 of 9 parenchymal and ductal changes (i.e. lobulations, hyperechoic stranding, hyperechoic foci, cysts, calcification, irregular duct, hyperechoic walls, side branch dilations and ductal calculi).
Exclusion Criteria
* Unable to safely undergo EUS for any reason
* Coagulopathy (INR \>1.6, Prothrombin Time \>18secs, Thrombocytopenia \<80,000 cells/ml)
* Unable to consent
* Non-English speaking patients.
* Previously undergone CPB
* Pregnancy and Breast feeding
* Patients with ductal strictures, calcification, pancreatic ductal calculi, pseudocysts.
* Previous pancreatic surgery
* Previous pseudocyst drainage
* Other documented causes of abdominal pain.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charles Mel Wilcox, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles M Wilcox, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F130822012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.